Objectives: To study the epidemio-clinical, therapeutic and evolutionary aspects of
laryngeal cancers in the ENT department of the University Hospital Gabriel
Toure.Materials and Methods: This was a descriptive, retrospective study over a period of 11 years
from January 2008 to December 2019. We made an exhaustive sampling of all cases
of malignant tumors of the larynx in the ENT department of the University Hospital Gabriel
TOURE. Variables studied: frequency, sex, age, clinic, imaging, histology, TNM
classification, treatment received and follow-up time was 1 to 11 years.Result: we noted a male predominance (44 men/13 women). The average age was 52.23
years, with extremes of 32 and 74 years. Smoking was reported by 40 patients
(72% of cases). The average in pack-years is
29.32 with extremes of 4 to 60 packs/year.
Alcoholism was reported by 6 patients (9% of cases). Squamous cell carcinoma
was the predominant histological type (100%); extension to 2 or 3 floors was objectified in 69% of cases. Complementary
radiotherapy in 26 patients after total laryngectomy. Chemotherapy was done in
a neoadjuvant situation in 36 cases. Overall survival was: 52.6% at 1 year,
33.3% at 3 years; 26.3% at 5 years and 12.28% at 11 years. Conclusion: Most often, late diagnosis is due to the absence of a national strategy and the
underestimation of the first symptoms. Surgery coupled with radiotherapy is the
treatment of choice.
References
[1]
Prades, J.-M. and Reyt, E. (2013) Cancers du larynx. EMC-Oto-Rhino-Laryngologie, 8, 1-15.
[2]
Defossez, G., Le Guyader-Peyrou, S. and Uhry, Z., et al. (2019) Estimations nationales de l’incidence et de la mortalité par cancer en France métropolitaine entre 1990 et 2018. Santé publique France, Saint-Maurice.
[3]
Institut national du cancer (2018) Les cancers en France, édition 2017. Institut national du cancer, Boulogne-Billancourt.
[4]
Daniel, B., Denis, A., Stephane, H., Dana, H. and Jean Francois, P. (2008) Traité d’ORL. In Jean L, Sophie P. Cancer de larynx et l’hyopharynx. Médecine science Flammarion, Paris, 588-595.
[5]
Service d’anatomie cytologie pathologie (2018) rapport des registres des cancers au Mali. registre des cancers du Mali.
[6]
Asmae, M. (2019) Laryngectomie totale: Expérience du service d’ORL du CHU Hassan II de Fès à propos de 32 cas. Faculte de Medecine et de Pharmacie de Fès, Sidi Harazem Fès.
[7]
Gauche, C. (2016) Prise en charge ganglionnaire des cancers du larynx classé T1-T2N0, à propos de 384 cas. Faculté de médecine Toulouse-III-Paul-Sabatier, Toulouse.
[8]
Lefebvre, J.-L. and Chevalier, D. (2005) Cancers du larynx. EMC-Oto-Rhino-Lary ngologie, 2, 432-457. https://doi.org/10.1016/j.emcorl.2005.09.005
[9]
Gallus, S., Bosetti, C., Franceschi, S. and Levi, F. (2003) Laryngeal Cancer in Women: Tobacco, Alcohol, Nutritional and Hormonal Factors. Cancer Epidemiol Biomarkers Prevention, 12, 514-517.
[10]
Talamini, R., et al. (2012) Combined Effect of Tobacco and Alcohol on Laryngeal Cancer Risk: A Case-Control Study. Cancer Causes Control, 13, 957-964. https://doi.org/10.1023/A:1021944123914
[11]
Lamyae, M. (2011) Le cancer du larynx (A propos de 34 cas). Faculté de médecine et de pharmacie de Fès, Sidi Harazem Fès.
[12]
Sadek, H. (2010) Profils épidémiologique, clinique, thérapeutique et évolutif du cancer de larynx au service d’oncologie du CHU Mohamed VI entre 2003 et 2008 à propos de 34 cas. Faculté de médecine et de pharmacie de Fès, Sidi Harazem Fès.
[13]
Diakité, A. (2005) Cancer du larynx: Expérience de l’institut national d’oncologie de Rabat, à propos de 404 cas. Cancer/Radiothérapie, 16, 545. https://doi.org/10.1016/j.canrad.2012.07.085
[14]
Obid, R. Redlich, M. and Tomeh, C. (2019) Tomeh, The Treatment of Laryngeal Cancer. Oral and Maxillofacial Surgery Clinics of North America, 31, 1 11. https://doi.org/10.1016/j.coms.2018.09.001
